Episode Details
Back to Episodes
Ep. 533 “Under 60 or Else?” – The Dangerous Myth Limiting Women’s Hormone Therapy
Description
We have another AMA episode today, where I answer some of the most frequently asked podcast listener questions.
In response to a question from Catherine, we unpack the timing hypothesis in this episode, exploring the cardiovascular nuances and clarifying why individualized care truly matters.
IN THIS EPISODE, YOU WILL LEARN:
-
Cardiovascular and metabolic benefits of starting hormone therapy within about 10 years of menopause onset
-
What the timing hypothesis really means in clinical practice
-
Why feeling better does not necessarily imply long-term disease risk has been reduced
-
How endothelial (blood vessel) health influences the effectiveness of hormone therapy
-
Why metabolic changes after menopause matter more than most women realize
-
How their hormone therapy decisions must change as women move further beyond menopause
-
Risks and benefits of oral versus transdermal hormone delivery
-
Value of shared patient-clinician decision-making
-
How lifestyle habits and risk assessment form the foundation for safe, effective, and personalized hormone therapy decisions
Connect with Cynthia Thurlow
-
Check out Cynthia’s website
-
Submit your questions to support@cynthiathurlow.com
-
Join other like-minded women in a supportive, nurturing community: The Midlife Pause/Cynthia Thurlow
-
Cynthia’s Menopause Gut Book is on presale now!
-
Cynthia’s Intermittent Fasting Transformation Book